A volta das sexy symbols aos 50 anos em Hollywood
No Globo de Ouro, quando Fernanda Torres, 59, ganhou o prêmio de melhor atriz, ao seu lado, estavam apenas mulheres acima dos 50 anos concorrendo à estatueta de Melhor Atriz. Entre as indicadas: Pamel ...
C.E.O.s Look Beyond a Rosy Inflation Report
Better-than-expected price data can’t quite blunt worries about consumers pulling back, as companies keep scrambling to ...
Zero Candida Commences Trading on OTCQB Market
Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing ...
Yahoo Finance6d
Novo’s New Obesity Drug Disappoints Again, This Time in Diabetes
(Bloomberg) -- Novo Nordisk A/S shares plunged the most since December after another disappointment for the drugmaker’s next-generation shot CagriSema. The medicine helped patients with diabetes ...
Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment (Rating Downgrade)
Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation
Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency ("RF") Generator On track for Investigational Device Exemptio ...
publico3d
Novo coronavírus. O que precisa de saber
O novo coronavírus infectou milhares de pessoas, colocou os países em alerta e ameaça o ritmo da economia global. Acompanhe aqui tudo o que se passa. Cientistas avisam que estamos cada vez mais ...
pharmaphorum1d
Novo completes $16.5bn takeover of Catalent
Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.
Seeking Alpha2d
DD DuPont de Nemours, Inc.
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through ...
pharmaphorum4d
Novo joins Lilly in asking FDA for ban on GLP-1 compounding
Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...